# A Real World Experience of Dapagliflozin in Type 2 Diabetes

> **NCT02966626** · — · COMPLETED · sponsor: **University of Malaya** · enrollment: 223 (actual)

## Conditions studied

- Type2 Diabetes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02966626
- **Lead sponsor:** University of Malaya
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2017-09
- **Final completion:** 2018-01
- **Target enrollment:** 223 (ACTUAL)
- **Last updated:** 2018-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02966626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02966626, "A Real World Experience of Dapagliflozin in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02966626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*